Apoptosis induced in human cell lines by a butanol extract from Chlorophytum comosum roots

Journal of Health Science

Volumn 51, Issue 3, 2005, Pages 341-345

  Matsushita, Hirohisa ^a,b   Kuwabara, Hiroaki ^b   Ishikawa, Satoko ^b   Mochizuki, Masataka ^b  

^a Bioscience Research and Development Center   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Apoptosis; CCRF HSB 2; Chlorophytum comosum

Indexed keywords

BUTANOL; CHLOROPHYTUM COMOSUM EXTRACT; DACTINOMYCIN; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHLOROPHYTUM COMOSUM; CONTROLLED STUDY; DNA STRAND BREAKAGE; ELECTROPHORESIS; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; MICROSCOPY; NICK END LABELING; PLANT; PLANT ROOT;

ARANEAE; CHLOROPHYTUM COMOSUM;

EID: 21144440555     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.51.341     Document Type: Article

References (19)

1. Wyllie, A. H., Kerr, J. F. and Currie, A. R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306.
2. Tsuruo, T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H. and Haga, N. (2003) Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Res., 94, 14-21.
3. Walker, N. I., Harmon, B. V., Gobe, G. C. and Kerr, J. F. (1988) Patterns of cell death. Methods Achiev. Exp. Pathol., 13, 18-54.
4. McConkey, D. J., Orrenius, S. and Jondal, M. (1990) Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol., 145, 1227-1230.
5. Cohen, J. J. (1993) Apoptosis. Immunol. Today, 14, 126-130.
6. Wyllie, A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London), 284, 555-556.
7. Vedeckis, W. V. and Bradshaw, H. D. (1983) DNA fragmentation in S49 lymphoma cells killed with glucocorticoids and other agents. Mol. Cell. Endocrinol., 30, 215-227.
8. McConkey, D. J., Hartzell, P., Nicotera, P. and Orrenius, S. (1989) Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J., 3, 1843-1849.
9. Tokino, K., Matsushita, H., Ohno, T. and Mochizuki, M. (2000) A human leukemia cell line CCRF-HSB-2 is useful for the screening of antitumor activity. Tumor Res., 35, 49-55.
10. Pasechnik, V. (2000) Microbial pathogens and apoptotic anticancer therapy. Expert. Opin. Investig. Drugs, 9, 1243-1256.
11. Jiang Su New Medical College (ed.) (1977) Dictionary of Traditional Chinese Crude Drugs, vol. 2 (Jiang, S., Ed.), Shanghai Scientific Technologic, Shanghai, p. 1636.
12. Mimaki, Y., Kanmoto, T., Sashida, Y., Satomi, Y. and Nishimo, H. (1996) Steroidal saponins from the underground parts of Chlorophytum comosum and their inhibitory activity on tumor promoter-induce phospholipids metabolism of HeLa cells. Phytochemistry, 41, 1405-1410.
13. Ishiyama, M., Tominaga, H., Shiga, M., Sasamoto, K., Ohkura, Y. and Ueno, K. (1996) A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull., 19, 1518-1520.
14. Jones, D. P., McConkey, D. J., Nicotera, P. and Orrenius, S. (1989) Calcium-activated DNA fragmentation in rat liver nuclei. J. Biol. Chem., 264, 6398-6403.
15. Carbonari, M., Cibati, M. and Fiorilli, M. (1995) Measurement of apoptotic cell in peripheral blood. Cytometry, 22, 161-167.
16. Martin, S. J., Lennon, S. V. and Bonham, A. M. (1990) Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol., 15, 1859-1867.
17. Hietanen, S., Lain, S., Krausz, E. and Blattner, C. (2000) Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. U.S.A., 18, 8501-8506.
18. Bicknell, G. R., Snowden, R. T. and Cohen, G. M. (1994) Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937. J. Cell Sci., 107, 2483-2489.
19. Adjei, A. A. and Rowinsky, E. K. (2003) Novel anticancer agents in clinical development. Cancer Biol. Ther., 2, 5-15.